Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04109729
Title Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer (Rad2Nivo)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Utah

prostate adenocarcinoma


Nivolumab + Radium Ra 223 dichloride

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.